Home
Bioasis Technologies, Inc.

Bioasis Technologies, Inc. Market Share Analysis for June 2026

bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable diseases of the central nervous system.

Industry: N/A

Domainbioasis.us

Year Founded2007

Employees> 10001

Annual Revenue> $1B

Bioasis Technologies, Inc.

Bioasis Technologies, Inc. (including company regionals)

bioasis.us

See more website traffic and engagement information

Bioasis Technologies, Inc. Revenue up to June 2026 is > 1B

revenue generated by Bioasis Technologies, Inc. top domains

Bioasis Technologies, Inc. top domains revenue over 3 years

Revenue for Bioasis Technologies, Inc. top domains

bioasis.us> 1B

See more with Sales Intelligence

Total visits to Bioasis Technologies, Inc.'s top domains

Understand Bioasis Technologies, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Bioasis Technologies, Inc.'s top domains

Analyze Bioasis Technologies, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Bioasis Technologies, Inc.'s top domains

See how Bioasis Technologies, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Bioasis Technologies, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Bioasis Technologies, Inc.

These are the website technologies, by industry, used by Bioasis Technologies, Inc. top domains

Advertising (8)

DoubleClick

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Bioasis Technologies, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMidatech partners with biOasis Technologies Inc..With just enough cash to stay afloat until the first quarter, Midatech is linking up with US-based, Canada-listed Bioasis to create a new rare disease player, Biodexa.

NewsMidatech Pharma PLC acquired biOasis Technologies Inc. on Dec 15th '22.Midatech has also entered into securities purchase agreement with an institutional investor for (i) a registered direct offering of ADSs for gross proceeds of approximately US$400,000 that is expected to be completed on or about December 15, 2022 and a private placement equity financing for gross proceeds of approximately US$9.6M that will be completed concurrently with Midatech’s acquisition of Bioasis.

NewsbiOasis Technologies Inc. partnered with Neuramedy Co.,Ltd on Jul 30th '22.Bioasis recently announced partnerships with Janssen Biotech, a Johnson & Johnson company, and Korea-based Neuramedy Co. to ensure their proprietary xB3 technology is used as broadly as possible, to benefit as many people as possible Globally, 1.25 billion people suffer from neurological conditions including Alzheimer’s and other forms of dementia, cancers, rare genetic disorders present from birth, ALS, Parkinson’s, and hundreds more.